Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

 

Oral Abstract NHL 102: Axicabtagene Ciloleucel in Patients With Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1

106 views
October 25, 2018
Comments 0
Login to view comments. Click here to Login